Literature DB >> 22231486

DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility.

XiaoRi Lian1, Rong Xiao, XinHong Hu, Takuro Kanekura, HongYan Jiang, YaPing Li, YaoYao Wang, Yan Yang, Ming Zhao, QianJin Lu.   

Abstract

OBJECTIVE: Systemic sclerosis (SSc) is an autoimmune disease with a predilection for women. The interaction between CD40 and CD154 (CD40L) is known to be involved in the development of SSc. Although CD40L is overexpressed in patients with SSc, the mechanisms leading to this overexpression are not well understood. We previously demonstrated that DNA demethylation reactivates the silent X chromosome, resulting in CD40L overexpression in healthy women. We hypothesized that CD40L up-regulation by DNA demethylation and subsequent reactivation of the silent X chromosome in female patients with SSc explain the susceptibility of women to SSc. The aim of this study was to investigate the effect of DNA demethylation on CD40L expression in CD4+ T cells from female patients with SSc.
METHODS: CD40L expression in CD4+ T cells from patients with SSc and healthy control subjects was measured by flow cytometry and real-time reverse transcription-polymerase chain reaction. Bisulfite sequencing was performed to determine the methylation status of the CD40L regulatory region.
RESULTS: CD40L expression was significantly elevated in female patients with SSc. The methylation levels of the DNA regulatory sequences were reduced in female patients with SSc compared with healthy women, and there was a significant inverse correlation between the average methylation level and CD40L mRNA expression in female patients with SSc. In contrast, no significant difference was observed in the expression of CD40L between male patients with SSc and male control subjects. The DNA regulatory regions in both male patients and male control subjects were largely unmethylated.
CONCLUSION: Demethylation of CD40L regulatory elements on the inactive X chromosome contributes to CD40L overexpression in CD4+ T cells from female patients with SSc.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22231486     DOI: 10.1002/art.34376

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  45 in total

Review 1.  The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Maria Clorinda Mazzarino
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 2.  A new look at rheumatology in China--opportunities and challenges.

Authors:  Zhan-Guo Li
Journal:  Nat Rev Rheumatol       Date:  2015-01-20       Impact factor: 20.543

Review 3.  Epigenetics and systemic sclerosis.

Authors:  Nezam Altorok; Bashar Kahaleh
Journal:  Semin Immunopathol       Date:  2015-07-11       Impact factor: 9.623

Review 4.  Environmental risk factors of systemic sclerosis.

Authors:  Isabelle Marie; Jean-François Gehanno
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

Review 5.  Epigenetics in the pathogenesis of RA.

Authors:  Caroline Ospelt; Steffen Gay; Kerstin Klein
Journal:  Semin Immunopathol       Date:  2017-03-21       Impact factor: 9.623

Review 6.  Epigenetic drug discovery: breaking through the immune barrier.

Authors:  David F Tough; Paul P Tak; Alexander Tarakhovsky; Rab K Prinjha
Journal:  Nat Rev Drug Discov       Date:  2016-10-21       Impact factor: 84.694

Review 7.  Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Authors:  Guillermo Barturen; Lorenzo Beretta; Ricard Cervera; Ronald Van Vollenhoven; Marta E Alarcón-Riquelme
Journal:  Nat Rev Rheumatol       Date:  2018-01-24       Impact factor: 20.543

Review 8.  New insights into the epigenetics of inflammatory rheumatic diseases.

Authors:  Esteban Ballestar; Tianlu Li
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

9.  New insight on the Xq28 association with systemic sclerosis.

Authors:  F David Carmona; M Carmen Cénit; Lina-Marcela Diaz-Gallo; Jasper C A Broen; Carmen P Simeón; Patricia E Carreira; José-Luis Callejas-Rubio; Vicente Fonollosa; Francisco J López-Longo; Miguel A González-Gay; Nicolas Hunzelmann; Gabriela Riemekasten; Torsten Witte; Alexander Kreuter; Jörg H W Distler; Rajan Madhok; Paul Shiels; Jacob M van Laar; Annemie J Schuerwegh; Madelon C Vonk; Alexandre E Voskuyl; Carmen Fonseca; Christopher P Denton; Ariane Herrick; Jane Worthington; Frank C Arnett; Filemon K Tan; Shervin Assassi; Timothy R D J Radstake; Maureen D Mayes; Javier Martín
Journal:  Ann Rheum Dis       Date:  2013-02-26       Impact factor: 19.103

Review 10.  Clinical value of DNA methylation markers in autoimmune rheumatic diseases.

Authors:  Esteban Ballestar; Amr H Sawalha; Qianjin Lu
Journal:  Nat Rev Rheumatol       Date:  2020-08-05       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.